PL363427A1 - Kombinacje zawierające środek przeciwbiegunkowy iepotylon lub pochodną epotylonową - Google Patents
Kombinacje zawierające środek przeciwbiegunkowy iepotylon lub pochodną epotylonowąInfo
- Publication number
- PL363427A1 PL363427A1 PL02363427A PL36342702A PL363427A1 PL 363427 A1 PL363427 A1 PL 363427A1 PL 02363427 A PL02363427 A PL 02363427A PL 36342702 A PL36342702 A PL 36342702A PL 363427 A1 PL363427 A1 PL 363427A1
- Authority
- PL
- Poland
- Prior art keywords
- epothilone
- combinations
- antidiarrheal agent
- derivative
- antidiarrheal
- Prior art date
Links
- 150000003883 epothilone derivatives Chemical class 0.000 title abstract 3
- 229940125714 antidiarrheal agent Drugs 0.000 title abstract 2
- 239000003793 antidiarrheal agent Substances 0.000 title abstract 2
- 229930013356 epothilone Natural products 0.000 title 1
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 abstract 1
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27715301P | 2001-03-19 | 2001-03-19 | |
| US60/277153 | 2001-03-19 | ||
| US27720701P | 2001-03-20 | 2001-03-20 | |
| US60/277207 | 2001-03-20 | ||
| PCT/EP2002/002977 WO2002074042A2 (en) | 2001-03-19 | 2002-03-18 | Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL363427A1 true PL363427A1 (pl) | 2004-11-15 |
| PL206847B1 PL206847B1 (pl) | 2010-09-30 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL157333A0 (en) | Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative | |
| MY120601A (en) | C-21 modified epothilones | |
| AU2003237367A1 (en) | Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer | |
| IL164249A0 (en) | Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use | |
| AP2003002857A0 (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors. | |
| CA100209S (en) | Handle | |
| MXPA03004644A (es) | Derivados de fenilacetamdia-pirazol y su uso como agentes antitumorales. | |
| AU6989800A (en) | Diamino-1,2,4-triazole-carboxylic and derivatives as gsk-3 inhibitors | |
| EP1769791A3 (en) | Treatment of Alzheimer's disease with cell cycle inhibitors | |
| AU2003283216A1 (en) | Combination treatment using exendin-4 and thiazolidinediones | |
| AU2002228317A1 (en) | Benz-1,3-azole derivatives and their uses as heparanase inhibitors | |
| AU2003303388A1 (en) | Triptolide derivatives and their use | |
| WO2003088748A8 (en) | Use of heme oxygenase-1 and products of heme degradation | |
| SE9904377D0 (sv) | Pharmaceutical combinations | |
| AU2001222215A1 (en) | Lumbago treating girdle | |
| AU2002347747A1 (en) | Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents | |
| MXPA03003741A (es) | Metodos y composiciones para el tratamiento de enfermedades oftalmicas. | |
| ZA200307306B (en) | Indolines, substituted in portion 6, and their use as kinase inhibitors. | |
| WO2003063725A3 (en) | Methods of preventing and treating flavivirus infection in animals | |
| ZA200309513B (en) | Novel heterocyclic derivatives and medicinal use thereof. | |
| ZA200501288B (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma. | |
| AU2002239395A1 (en) | Hiv treatment with benzimidazoles | |
| AU2525201A (en) | Combination of cyamemazine and an atypical neuroleptic | |
| IL164356A0 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy | |
| AU2003288263A1 (en) | Use of substituted acrylolyl distamycin derivatives in combination with demethylating agents, in the treatment of cancer |